NIA Impact Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,931
| Closed | -$124K | – | 61 |
|
|
2022
Q4 | $124K | Sell |
13,931
-10,488
| -43% | -$93K | 0.07% | 56 |
|
|
2022
Q3 | $299K | Sell |
24,419
-70,284
| -74% | -$861K | 0.18% | 56 |
|
|
2022
Q2 | $1.12M | Sell |
94,703
-59,551
| -39% | -$704K | 0.67% | 51 |
|
|
2022
Q1 | $2.93M | Buy |
154,254
+65,381
| +74% | +$1.24M | 1.42% | 27 |
|
|
2021
Q4 | $1.54M | Buy |
88,873
+6,639
| +8% | +$115K | 0.82% | 40 |
|
|
2021
Q3 | $3.38M | Buy |
82,234
+11,870
| +17% | +$488K | 1.44% | 29 |
|
|
2021
Q2 | $3.99M | Buy |
70,364
+5,280
| +8% | +$299K | 1.94% | 20 |
|
|
2021
Q1 | $2.73M | Buy |
65,084
+10,469
| +19% | +$440K | 1.48% | 31 |
|
|
2020
Q4 | $4.9M | Buy |
+54,615
| New | +$4.9M | 2.55% | 15 |
|